Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations evidence for a threshold effect

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 12, 1998, Pages 1870-1876

  Gaw, Allan ^a,b   Ann Brown, E ^a   Ford, Ian ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apolipoprotein(a); Lipoprotein(a); Polymorphism phenotyping

Indexed keywords

APOLIPOPROTEIN A1; GLYCOPROTEIN; LIPOPROTEIN A;

ALLELE; ARTICLE; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENE LOCUS; HUMAN; HUMAN CELL; HYDROPHILICITY; LIPOPROTEIN BLOOD LEVEL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA TRANSLATION; TANDEM REPEAT;

EID: 17344362029     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.12.1870     Document Type: Article

References (12)

1. Utermann G. Lipoprotein(a). In: Scriver CR, Beaudet A, Sly WS, Valle D, editors. The Metabolic Basis of Inherited Disease. New York, NY: McGraw Hill Inc; 1995:1887-1912.
2. Gaw A, Hobbs HH. Molecular genetics of lipoprotein (a): new pieces to the puzzle. Curr Opin Lipidol. 1994;5:149-155.
3. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, Seidel D. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest. 1994;24:444-453.
4. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: a prospective study. JAMA. 1996;276:544-548.
5. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80:458-465.
6. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991;87:2077-2086.
7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52-60.
8. Boerwinkle E, Menzel HG, Kraft HG, Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait. III: contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet. 1989;82:73-78.
9. Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res. 1990;31:603-613.
10. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups: evidence for no common "null" allele at the apo(a) locus. J Clin Invest. 1994;93:2526-2534.
11. WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Study. Am J Cardiol. 1995;76:485-491.
12. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Eng; J Med. 1995;333: 1301-1307.